<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR89523-0074 </DOCNO><DOCID>fr.5-23-89.f2.A1073</DOCID><TEXT><ITAG tagnum="94"><ITAG tagnum="69"><ITAG tagnum="50">DEPARTMENT OF HEALTH AND HUMAN SERVICES</ITAG><ITAG tagnum="18">Food and Drug Administration</ITAG><ITAG tagnum="52">Request for Nominations for Members on Public Advisory Committees</ITAG><ITAG tagnum="10"><T2>AGENCY: </T2>Food and Drug Administration.</ITAG><ITAG tagnum="10"><T2>ACTION: </T2>Notice. </ITAG><ITAG tagnum="10"><T2>SUMMARY: </T2>The Food and Drug Administration (FDA) is requestingnominations for members to serve on certain public advisory committeesin the Center for Biologics Evaluation and Research. Nominations will beaccepted for current vacancies and vacancies that will or may occur onthe committees during the next 12 months and beyond. FDA has a special interest in ensuring that women, minority groups, andthe physically handicapped are adequately represented on advisory committeesand, therefore, extends particular encouragement to nominations for appropriatelyqualified female, minority, and physically handicapped candidates. Finalselection from among qualified candidates for each vacancy will be determinedby the expertise required to meet specific agency needs and in a mannerto ensure appropriate balance of membership.</ITAG><ITAG tagnum="10"><T2>DATE: </T2>Because scheduled vacancies occur on various dates throughouteach year, no cutoff date is established for receipt of nominations.</ITAG><ITAG tagnum="10"><T2>ADDRESSES: </T2>All nominations for membership, except for consumer-nominatedmembers, should be sent to Jack Gertzog (address below). All nominationsfor consumer-nominated members should be sent to Catherine Beck (addressbelow).</ITAG><ITAG tagnum="10"><T2>FOR FURTHER INFORMATION CONTACT:</T2><ITAG tagnum="15">Jack Gertzog, Advisors and Consultants Staff (HFD-9), Center for BiologicsEvaluation and Research, Food and Drug Administration, 5600 Fishers Lane,Rockville, MD 20857, 301-443-5455. </ITAG></ITAG><ITAG tagnum="10">or <ITAG tagnum="15">Catherine P. Beck, Office of Consumer Affairs (HFE-40), Food and DrugAdministration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-5006.</ITAG></ITAG><ITAG tagnum="10"><T2>SUPPLEMENTARY INFORMATION: </T2>FDA is requesting nominations of membersfor the following three advisory committees for vacancies listed below.Individuals should have expertise in the activity of the committee. 1. Allergenic Products Advisory Committee: Three vacancies occurring August31, 1989. 2. Blood Products Advisory Committee: Four vacancies occurring September30, 1989. 3. Vaccines and Related Biological Products Advisory Committee: Two vacanciesoccurring January 31, 1990. The function of the three committees listed above are to review and evaluateavailable scientific, technical, and medical data concerning the safety,effectiveness, and appropriate use of allergenic products, blood and productsderived from blood and serum, vaccines, immunological products, and otherbiological products intended for use in the diagnosis, prevention, or treatmentof human diseases, and to make appropriate recommendations to the Commissioner.These three committees also review and evaluate intramural research programs.<ITAG tagnum="84">Criteria for Members </ITAG>Persons nominated for membership on the committees described above musthave adequately diversified research and/or clinical experience appropriateto the work of the committee in such fields as allergenic products, infectiousdiseases, internal medicine, epidemiology, statistics, hematology, immunology,blood banking, virology, bacteriology, pediatrics, microbiology, nuclearbiology, and biochemistry, or other appropriate areas of expertise. The specialized training and experience necessary to qualify the nomineeas an expert suitable for appointment is subject to review, but may includeexperience in medical practice, teaching, research, and/or public servicerelevant to the field of activity of the committee. The term of officeis 4 years.<ITAG tagnum="84">Criteria for Consumer-Nominated Members </ITAG>FDA currently attempts to place on each of the committees described aboveone voting member who is nominated by consumer organizations. These membersare recommended by a consortium of 12 consumer organizations which hasthe responsibility for screening, interviewing, and recommending consumer-nominatedcandidates with appropriate scientific credentials. Candidates are soughtwho are aware of the consumer impact of committee issues, but who alsopossess enough technical background to understand and contribute to thecommittee's work. This would involve, for example, an understanding ofresearch design, benefit/risk, and the legal requirements for safety andefficacy of the products under review, and considerations regarding individualproducts. The agency notes, however, that for some advisory committees,it may require such nominees to meet the same technical qualificationsand specialized training required of other expert members of the committee.The term of office for these members is 4 years. Nominations for all committeeslisted above are invited for consideration for membership as openings becomeavailable. <ITAG tagnum="84">Nomination Procedure </ITAG>Any interested person may nominate one or more qualified persons for membershipon one or more of the advisory committees. Nominations shall specify thecommittee for which the nominee is recommended. Nominations shall statethat the nominee is aware of the nomination, is willing to serve as a memberof the advisory committee, and appears to have no conflict of interestthat would preclude committee membership. Potential candidates will beasked by FDA to provide detailed information concerning such matters asfinancial holdings, consultancies, and research grants or contracts inorder to permit evaluation of possible sources of conflict of interest.This notice is issued under the Federal Advisory Committee Act (Pub. L.92-463, 86 Stat. 770-776 (5 U.S.C. App. I)) and 21 CFR Part 14, relatingto advisory committees.<ITAG tagnum="21">Dated: May 17, 1989. </ITAG><ITAG tagnum="6">John M. Taylor, </ITAG><ITAG tagnum="4">Associate Commissioner for Regulatory Affairs.</ITAG><ITAG tagnum="40">[FR Doc. 89-12287 Filed 5-22-89; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4160-01-M</ITAG></ITAG></ITAG></ITAG></TEXT></DOC>